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Abstract
Aging leads to adverse outcomes after traumatic brain injury. The mechanisms underlying these defects, however, are not
yet clear. In this study, we found that astrocytes in the aged post-traumatic cerebral cortex develop a signiﬁcantly reduced
proliferative response, resulting in reduced astrocyte numbers in the penumbra. Moreover, experiments of reactive
astrocytes in vitro reveal that their diminished proliferation is due to an age-related switch in the division mode with
reduced cell-cycle re-entry rather than changes in cell-cycle length. Notably, reactive astrocytes in vivo and in vitro become
refractory to stimuli increasing their proliferation during aging, such as Sonic hedgehog signaling. These data demonstrate
for the ﬁrst time that age-dependent, most likely intrinsic changes in the proliferative program of reactive astrocytes result
in their severely hampered proliferative response to traumatic injury thereby affecting astrocyte homeostasis.
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Introduction
Aging is associated with a plethora of morphological, ultrastruc-
tural and epigenetic modiﬁcations, which can signiﬁcantly
impair brain functioning (Lynch et al. 2010; Chisholm et al.
2015). It is thus not surprising that the cellular reactions to path-
ological processes in the brain differ profoundly between young
and older organisms (Buga et al. 2008; Juraska and Lowry 2012).
Indeed, adverse recovery and poor outcome following traumatic
injury or ischemic episode in aged patients and experimental
animals provide compelling evidence that the young brain is
able to recover much better than the old one (Copen et al. 2001;
Badan et al. 2003; Zhang et al. 2005; Fonarow et al. 2010;
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Gargano et al. 2011; Pekna et al. 2012). Since the acute phase
events are of greatest importance for functional outcomes after
invasive brain injury (Alexander 1994; Moppett 2007; Dostovic
et al. 2009), the pronounced regenerative capacity within the
young brain parenchyma over the ﬁrst few days after a patho-
logical event may underlie better recovery from damage. It is
important to note that this short time span after damage is
characterized by various reactions of neurons and glial cells,
including astrocytes (Sirko et al. 2013; Burda and Sofroniew
2014). Due to the multiple roles that reactive astrocytes, and
especially their proliferating subset have (Burda and Sofroniew
2014; Verkhratsky et al. 2014a, 2014b; Anderson et al. 2016),
transcriptional mechanisms regulating their injury-induced
response have been the focus of recent studies in postnatal or
young adult animals (Zamanian et al. 2012; Sirko et al. 2015).
However, still relatively little is known about age-dependent
properties of astrocytes in the post-traumatic brain (see in
review Verkhratsky et al. 2016).
As physiological aging is associated with morphological and
molecular changes in astrocytes (Unger 1998; Lynch et al. 2010;
Middeldorp and Hol 2011; Orre et al. 2014), the region-speciﬁc
effects of aging on reactive astrocytes may potentially interfere
with restorative process within the injured parenchyma, and
consequently, limit the recovery of aged animals after lesion.
Especially, in the post-traumatic cerebral cortex gray matter
(GM), astrocytes have the potential to exert powerful and long-
term inﬂuences on regenerative processes through their injury-
induced proliferation, as in this brain region astrocytes do not
migrate toward the injury site, and recruitment of astroglial
population after injury relies solely on proliferation in a speciﬁc
niche (Bardehle et al. 2013). In spite of this, the effect of aging
on astrocyte proliferation and restoration of the astroglial equi-
librium in the injured GM is still unclear.
We, therefore, examined here the changes in proliferative
astrocyte response in the somatosensory GM of young, middle-
aged and old mice throughout the ﬁrst week post-injury. The
results of our study shed new light on how the aging process
changes the proliferative program of reactive astrocytes,
thereby impairing the recovery of astrocyte numbers in the
injured GM parenchyma.
Materials and Methods
Animals
Experiments were performed with C57BL/6 J mice (Charles River
Laboratories), Tg(Aldh1l1-eGFP)OFC789Gsat mice (Heintz 2004),
TgN(hGFAP-EGFP)GFEA mice (Nolte et al. 2001), and double
transgenic mice crossbred from TgN(GFAP-mRFP1) mice
(Hirrlinger et al. 2005) and B6.Cg-Tg(Fucci)504Bsi(RBRC02706)
(Fucci-S/G2/M-Green:mAG-hGeminin [1/110]) mice, expressing
the S/G2/M phase-speciﬁc fusion-protein mAG-hGeminin
(Sakaue-Sawano et al. 2008) (RIKEN BioResource Center).
Animals were allocated to experimental groups regarding their
genotype and kept under standard conditions with access to
water and food ad libitum. Animal handling and experimental
procedures were performed in accordance with German and
European Union guidelines and were approved by the State of
Upper Bavaria. All efforts were made to minimize suffering and
number of animals used.
Surgical Procedures
Stab wound injury was performed in the somatosensory cortex,
as previously described (Buffo et al. 2008; Heinrich et al. 2014).
Brieﬂy, animals were anesthetized and received a 1.2mm stab
wound into the cortical GM parenchyma with a lancet-shaped
knife (Alcon) along the anteroposterior axis at the following
coordinates from bregma: anteroposterior −0.8 to −2.0, medio-
lateral 1.6–2.0mm, and dorsoventral −0.6. For the in vivo treat-
ment with Smoothened agonist (SAG; Calbiochem) (Frank-
Kamenetsky et al. 2002), SAG (0.15mg in 0.5% methylcellulose/
0.2% Tween80 per 10 g body weight) was administered orally
once a day for 5 days, starting 2 h after stab wound injury (Sirko
et al. 2013). All experimental procedures were performed in
accordance with the animal welfare policies of, and approved
by the State of Bavaria.
Immunohistochemistry
After transcardial perfusion with phosphate-buffered saline
(PBS) and then 4% paraformaldehyde (PFA) in PBS, brains were
postﬁxed in 4% PFA for 4 h at 4 °C, and then cryoprotected in
30% sucrose in PBS. Sections of 40μm thickness were processed
for immunohistochemistry, as previously described (Simon
et al. 2011). The following primary antibodies were used: anti-
glial ﬁbrillary acidic protein (GFAP) (mouse, 1:400; Sigma-
Aldrich) or anti-GFAP (rabbit, 1:500; Dako), anti-BrdU (rat, 1:200;
Biozol), anti-Ki-67 (rabbit, 1:100; Life Technologies), anti-s100β
(mouse, 1:250; Sigma-Aldrich), anti-aldehyde dehydrogenase 1
family member L1 (Aldh1l1) (mouse, 1:200; Millipore), anti-Iba1
(rabbit, 1:500; Wako), and anti-NG2 (rabbit, 1:200; Chemicon). To
detect the various primary antibodies, we used subclass spe-
ciﬁc secondary antibodies coupled with Alexa488 (1:500),
Alexa594 (1:1000), Alexa633 (1:1000), Cy3 (1:500), or Cy5 (1:1000)
(all from Dianova). All antibodies were diluted in PBS-TritonX
with 10% normal goat serum. Proliferating cells were labeled
with 5′-bromo-deoxyuridine (BrdU; Sigma-Aldrich) added to the
drinking water (1mg/mL water containing 1% sucrose) for 5
consecutive days. BrdU incorporation was monitored in free-
ﬂoating sections pretreated with 0.01M sodium citrate (pH6) at
95 °C for 24min, as previously described (Simon et al. 2011).
Adherent Culture and Immunocytochemistry
For the adherent culture, cortical cells of the post-traumatic
somatosensory GM were dissociated with activated papain
(30 U/mL) from punched tissue samples covering an area of
1.25mm radius from the lesion site at 5 days post-injury (dpi).
After 15min at 37 °C, dissociation was stopped with ovomucoid
(1mg/mL trypsin inhibitor (Sigma), 50 μg/mL bovine serum albu-
min (Sigma), 40 μg/mL DNaseI (Worthington), in L-15 medium
(Sigma)), and the suspension was then centrifuged for 5min at
200g. Cells were resuspended in culture medium containing
Dulbecco’s Modiﬁed Eagle medium: nutrient mixture F-12
(DMEM/F-12), 10% fetal calf serum, 1% B27 Supplement, 2mM
L-Glutamine, 1% penicillin-streptomycin, FGF-2 and EGF both
at 20ng/mL (all from Invitrogen) and 200.000 cells were plated
in 2mL medium per well in 24-wells cell culture plates coated
with poly-L-ornithine (100 μg/mL) and laminin (20 μg/mL). To
adapt to culture conditions, cells were kept for 2 days without
medium change. After 2 days in vitro (div), debris was washed
off with PBS, and 2mL of freshly prepared medium with or
without SAG (0.5mM, Calbiochem) was added to cell cultures.
The cell culture plates were then transferred to the incubator of
the time-lapse microscope for continuous imaging for 7 days.
The number of surviving cells within individual cultures
was determined by using data recorded in the individual
wells at the beginning of time-lapse imaging (time point 0).
4214 | Cerebral Cortex, 2017, Vol. 27, No. 8
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/8/4213/3798185 by guest on 11 N
ovem
ber 2019
The average cell density was calculated per mm2 for each
experimental group. Although there were some variations in
the number of adherent cells between age-groups (166 ± 20,
147 ± 23, and 130 ± 25 cells/mm2 in the cultures prepared from
the injured GM of 2-, 6-, and 12-month-old animals, respectively,
n = 6), these differences were not signiﬁcant (P = 0.290, P = 0.289,
P = 0.330, 2 month vs. 6 month, 2 month vs. 12 month, 6 month
vs. 12 month, respectively). The growth proﬁle was determined
by analyses of cell numbers in the same cell cultures at the start
and end point (168 h) of imaging. The average expansion rate
among all cell cultures was 6.7 ± 0.8 (6.4 ± 0.8, 5.9 ± 0.6, and 7.9 ±
0.8 in the cultures prepared from the injured GM of 2-, 6-, and
12-month-old animals, respectively; n = 6) with no signiﬁcant
differences between experimental groups (P = 0.596, P = 0.102, P =
0.067, 2 month vs. 6 month, 2 month vs. 12 month, 6 month vs.
12 month, respectively), indicating that the cultured reactive glia
from young, middle-age, or old animals may grow in a similar
manner. The identity of the adherent cells at the start point of
live cell imaging was determined in cultures prepared in parallel,
which were ﬁxed and immunostained for GFAP (rabbit, 1:300;
Dako), Iba1 (rabbit, 1:300; Wako), NG2 (rabbit, 1:200; Chemicon),
O4 (mouse, 1:50; Millipore), NeuN (mouse, 1:250; Millipore), and
βIII-tubulin (mouse, 1:250; Promega), as previously described
(Sirko et al. 2009).
After time-lapse imaging, cells were ﬁxed and stained for
GFAP (rabbit, 1:300; Dako), βIII-tubulin (mouse, 1:250; Promega), and
O4 (mouse, 1:50; Millipore), as described previously (Sirko et al.
2015). Nuclei were visualized with 4′,6′-diamidino-2-phenylindole
(DAPI) (0.1mg/mL; Sigma-Aldrich). After immunostaining, cells
were imaged at the corresponding locations with the time-
lapse microscope. For the control experiments, we used cell
cultures prepared from the intact GM, as well as reactive gliosis
cells cultured in the cyclopamine-containing medium (5 nM,
Sigma-Aldrich).
Time-Lapse Video Microscopy
Time-lapse video microscopy and single-cell tracking of pri-
mary cortical cultures were carried out with a cell observer
(Zeiss) in an incubator with a constant temperature of 37 °C
and 5% CO2. Phase-contrast images were acquired every 5min
using a phase-contrast microscopy objective (Zeiss), ﬂuoro-
chrome images every 450min with an AxioCamHRm camera
and Zeiss AxioVision 4.7 software. Single-cell tracking was car-
ried out using a self-written computer program (Rieger et al.
2009; Hilsenbeck et al. 2016). Videos were assembled using
ImageJ 10.2 software (National Institutes of Health).
Neurosphere Culture
Neurosphere cultures were prepared from the cells of the
injured somatosensory GM tissue that was punched from areas
spanning 1.25mm in radius from the lesion site at 5 dpi.
Samples were digested with Trypsin (0.025%) for 20min at 37 °C
and digestion was stopped with the ovomucoid-containing solu-
tion described above. Cells were centrifuged at 1500 r.p.m. for
5min, resuspended in neurosphere medium containing DMEM/F-
12, 1% B27 Supplement, 2mM L-Glutamine, 1% penicillin-
streptomycin, FGF-2, and EGF both at 20ng/mL (all from
Invitrogen) and plated in 24-wells cell culture plates at a density
of 5 cells/μL. For some experiments, we used 0.5mM SAG
(Calbiochem), which was added at the beginning of the experi-
ment only. The number and size of generated neurospheres was
determined after 7 or 14 div, and individual neurospheres were
assessed for self-renewal as described earlier (Sirko et al. 2015).
Puriﬁcation of cells using Fluorescence-Activated Cell
Sorting
Single-cell suspensions were prepared from the somatosensory
GM tissue of either intact mice (2 animals per age-group in dis-
tinct biological samples) or injured mice (3 animals per age-
group in pooled biological samples) using the same procedure
as described above. Following dissociation, cells were resuspended
in medium containing DMEM/F-12, 1% B27 Supplement, 2mM
L-Glutamine, 1% penicillin-streptomycin (all from Invitrogen),
and ﬁltered with a 40μm strainer. Cell viability was determined
via staining with propidium iodide (1:1000, Sigma) in parallel
samples processed from C57Bl/6 mice. GFAP-mRFP+, GFAP-GFP+,
and Aldh1l1-eGFP+ cells were isolated by ﬂuorescence-activated
cell sorting (FACSAria, BD). Gating parameters were set by side
and forward scatter to eliminate debris and aggregated cells.
Cells were sorted into RNAse-free eppendorfs containing RLT
buffer with 1% β-mercaptoethanol and further processed for
qPCR analysis.
RNA Extraction and Quantitative RT-PCR
RNA from FACS-sorted cells was extracted with the RNeasy
Plus Micro Kit (Qiagen) according to manufacturer’s instruc-
tions, and genomic DNA was removed. RNA was retro-
transcribed with SuperScriptIII Reverse Transcriptase and
Random Primers (Roche). Real-time qPCR was performed on
LightCycler480 (Roche) with the LightCycler Probe Master kit
(Roche) and Monocolor Hydrolysis Probe (Roche) according to
manufacturer’s instructions. The expression of each gene was
analyzed in 3 technical replicates per biological sample,
whereas each biological sample of the Aldh1l1-GFP+ astrocytes
was composed of a pool of cells sorted from the injured GM tis-
sue from 3 animals per age-group. Data were processed with
the ΔΔCt method (Livak and Schmittgen 2001) and the levels of
gene transcripts were normalized to that of the hypoxanthine-
guanine phosphoribosyltransferase transcript. Primers and
probes used for the qPCR are listed in Supplementary Table 1.
BBB Leakage Analysis
At 5 dpi, animals were anesthetized and 100 μL of FITC-Dextran
were injected i.v. (ThermoFisher Scientiﬁc D3306, 5mg/mL).
After 1 h, the brains were removed and immediately frozen at
−80 °C. About 30μm brain slices were prepared using a cryostat.
Epiﬂuorecence images were directly taken for quantiﬁcation of
FITC ﬂuorescence or brieﬂy postﬁxed for 30min using 4% PFA,
washed once with PBS and stained with anti-mouse immuno-
globulin G (IgG) coupled to Alexa Fluor A647 (115-606-072,
Dianova, Germany, 1:500) for 2 h and DAPI for 5min. After
mounting and drying of sections, confocal images were taken
using constant exposure settings. Single channel maximum
intensity projections were subjected to automatic threshold
and used for quantiﬁcations of the ﬂuorescent area using NIH
ImageJ software.
Statistical Data Analysis
Confocal laser scanning (Zeiss LSM5; Zeiss LSM710) microscope
was used to quantify immunopositive cells in sections or cell
culture. For each of the quantiﬁcations, at least 3 animals or
experimental culture batches were examined. All quantiﬁcations
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of immunohistochemistry were based on analysis of at least 5
sections per animal. Statistical analyses of data were performed
using the GraphPrism 5.0 software. Data were tested for the nor-
mal distribution using the Kolmogorov–Smirnov test, and signiﬁ-
cance between means from 2 experimental groups was analyzed
using 2-tailed unpaired Student’s t-test and between multiple
groups by one-way analysis of variance (ANOVA) analysis. All
values were plotted as mean ± standard error of the mean (SEM),
unless otherwise stated. Signiﬁcance is indicated as *(P < 0.05),
**(P < 0.01), and ***(P < 0.001).
Results
Age-Related Changes in Astrocytes within the GM of the
Somatosensory Cerebral Cortex
Given previous evidence for changes in astrocytes during phys-
iological aging in human or rodent brains (Orre et al. 2014;
Rodriguez et al. 2014), we ﬁrst investigated whether the process
of aging is associated with phenotypical changes in astrocytes
of the somatosensory GM in 3 experimental cohorts of mice:
young (2–3 months of age), middle-aged (6–9 months of age),
and old (12–18 months of age). Similar to observations in other
regions of the cerebral cortex (Rodriguez et al. 2014), aging
induced a progressive increase of GFAP-immunopositive astro-
cytes also in the somatosensory GM (Fig. 1A). Interestingly, the
total number of astrocytes labeled by S100β remained the
same, while the proportion of GFAP+ astrocytes increased by
nearly 3-fold between 2 and 18 months of age (Fig. 1B). The
aging process induced not only a signiﬁcant increase of GFAP+
astrocytes but also changes in their morphology (Fig. 1C,D). In
contrast to the resting morphology of the Aldh1l1 immunoposi-
tive but GFAP-immunonegative in the somatosensory GM,
which remained comparable at all age stages studied, the pop-
ulation of Aldh1l1+GFAP+ astrocytes showed hypertrophy with
age (Fig. 1D). The age-related development of the activated
astrocyte phenotype is further corroborated by changes at the
transcriptional level, as determined by quantitative RT-PCR of
mRNA from GFAP-mRFP1+ astrocytes sorted by FACS from the
somatosensory GM of young and old transgenic mice (see
Supplementary Fig. 1A,B). Indeed, RFP+ cells isolated from old
animals showed not only higher expression levels of GFAP
mRNA than those in young mice (see Supplementary Fig. 1A),
but also elevated levels of STAT3 mRNA (see Supplementary
Fig. 1B). These data suggest that age-induced upregulation of
STAT3-dependent mechanisms, known to play a critical role in
activation of astrocytes and upregulation of GFAP expression
after injury (Sriram et al. 2004; Herrmann et al. 2008; Sofroniew
2009; O’Callaghan et al. 2014; Levine et al. 2016) may contribute
to the higher GFAP levels in aging.
Since the activated state of astrocytes is regarded as sign of
reactive astrogliosis, a process during which a subset of astro-
cytes can acquire a proliferative phenotype (Simon et al. 2011;
Sirko et al. 2013), we wondered whether astrocytes might also
resume proliferation during normal aging. In order to immuno-
label proliferating astrocytes, we supplied the nucleotide
analog-BrdU for 5 days in drinking water. Of note, the very few
BrdU+ astrocytes detectable in the cerebral cortex GM of
2-month-old mice (Simon et al. 2011; Sirko et al. 2013) became
even fewer with aging, such that starting with 12 months of
age, virtually no BrdU+GFAP+ cells were detected in the
somatosensory GM (see Supplementary Fig. 1D). Notably, also
the proliferative activity of other glial cell types, such as NG2+
glia or Iba1+ microglia, was not increased with aging. In
contrast to astrocytes, these glial cell types did not, however,
exhibit hypertrophy or an activated morphology (Supplementary
Fig. 1E,F). Thus, although astrocytes acquire a partially activated
phenotype, neither they nor other glial cells increased their pro-
liferation during normal aging.
Effect of Aging on Astrocyte Numbers and Homeostasis
after Traumatic Injury
Considering the age-associated changes in the GM astrocytes,
we also investigated the effects of aging on astrocyte reaction
to the stab wound injury in this region. In all experimental
groups, a stab wound induced heterogeneous astrocyte reac-
tions in the GM parenchyma, including hypertrophy, substan-
tial upregulation of GFAP, and polarization toward the wound
site (Fig. 2A). To investigate whether there are age-related dif-
ferences in the morphological phenotype of reactive astrocytes
in proximity or distance to the lesion core, we used double
staining with GFAP and Aldh1l1. At 5 dpi, the morphology of
reactive astrocytes within the post-traumatic GM was not uni-
form and varied with proximity to the lesion in both young and
old brains (Fig. 2B,C). However, there were obvious differences
between age groups. For instance, reactive astrocytes located in
close proximity to the lesion (within 300 μm) in old mice exhib-
ited a clear reduction of GFAP-immunoreactivity and less com-
plex processes compared with those in young animals (Fig. 2C).
Irrespectively of age, with increasing distance from the lesion,
astrocytes in the post-traumatic GM transitioned gradually to
their bushy morphologies with ﬁne branching processes.
Although most astrocytes within the penumbra gradually
reverted to their basic domain structure, there were some cases
in which elongated processes from activated astroglia entered
domains of neighboring astrocytes (Fig. 2C). However, in contrast
to the young animals, where cortical astrocytes exhibited almost
undetectable levels of GFAP starting with ~550μm distance to the
lesion, the radius of the area covered by GFAP-immunoreactivity
in old animals was signiﬁcantly increased (712 ± 64μm vs. 545 ±
56μm in 18-month-old vs. 2 month-old animals respectively; P =
0.011). This age-related enlargement of astrogliosis was not
linked to morphological alterations in aged astrocytes, as over
long distances to the lesion (≥400μm) the appearance, shape or
length of elongated processes of Aldh1l1+ astrocytes was well
comparable between young and old animals, but rather with the
retained upregulation of GFAP in aged astrocytes located even at
an 800μm distance to the lesion (Fig. 2B,C).
Despite an overall increased spread of astrogliosis in the
post-traumatic GM of aged animals, the density of GFAP+ cells
within the 300 μm wide region surrounding the lesion core
appeared to decrease with age (Fig. 2B,C and E). With distance
from the lesion core, however, this prominent gradient of
diminishing density of astroglial cells gradually transitioned to
a density similar to that seen in healthy GM tissue of the aged
brain (Fig. 2C). Consistent with the age-related decrease in den-
sity of GFAP+ cells in the area adjacent to the lesion and reduc-
tion of GFAP+ proﬁles of aged reactive astrocytes, also the
expression levels of GFAP mRNA in astrocytes sorted from the
somatosensory GM of 18-month-old Aldh1l1-eGFP transgenic
mice at 5 dpi was strongly decreased compared with Aldh1l1-
eGFP+ astrocytes from young animals at the same time point
after injury (Fig. 2J). That was different in young animals where
the population of GM astrocytes lost upon stab wound injury was
nearly replaced during the ﬁrst 5 days after injury (compare
Fig. 1B vs. 2D), suggesting that the ability to recover the astroglial
population in the post-traumatic GM decreases in the older brain.
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Age-Related Impairment of Proliferative Astrocyte
Response to Traumatic Injury
Since proliferation appears to be the only way to restore astro-
cyte numbers in the injured cerebral cortex (Bardehle et al. 2013),
the impaired restoration of normal astrocyte numbers after GM
injury in old animals may be due to failure of aged astrocytes to
either appropriately initiate or maintain their proliferative
response. Given that reactive astrocytes in young adult animals
reach their peak of proliferation at 5 dpi (Sirko et al. 2009, 2015),
Figure 1. Age-associated changes in astroglial population within the intact somatosensory GM. (A) Distribution of GFAP-immunopositive astrocytes in the intact fore-
brain of mice at 2, 9, and 18-month of age. High magniﬁcation images of the somatosensory GM correspond to the boxed regions (1–3). (B) Quantiﬁcation of S100β+
and GFAP+S100β+ cells within the somatosensory GM of young (2-month-old) and aged mice (18-month-old) indicates signiﬁcant increase in the number of GFAP+
cells in relation to normal aging, while the population of S100β+ astrocytes in this region of cerebral cortex remains unchanged. (C) Immunostaining of frontal brain
sections for GFAP and S100β showing a progressive change in both the frequency and morphology of GFAP+ cells, which are mostly located in the upper layer of the
somatosensory GM. High magniﬁcation images (1–3) correspond to the boxed regions and illustrate morphological changes in astroglial cells with age. (D) In contrast
to Aldh1l1+GFAP- astrocytes, the population of GFAP+ astrocytes (white arrowheads) in the somatosensory GM showed cellular hypertrophy with age. High magniﬁ-
cation images showing the changes in astroglial GFAP-proﬁle during the process of aging. Cell nuclei were counterstained with DAPI. Data are plotted as mean ± SEM
from n ≥ 3 independent experiments. Signiﬁcance between means was analyzed using 2-tailed unpaired Student’s t-test or between multiple groups by 1-way
ANOVA test and indicated as *P-value < 0.05, **P-value < 0.01, and ***P-value < 0.001. Scale bars: 200 μm in (A), 100 μm in (D), 75 μm in (C), and 20 μm in boxes.
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Figure 2. Age-dependent changes in proliferative astrocyte response to the stab wound injury of the GM. (A) Stab wound injury of the somatosensory GM induced a
broad expression of GFAP in parenchymal astrocytes at the injury site, as demonstrated by immunostaining with GFAP and Aldh1l1 at 5 dpi. (B) Representative over-
view images reveal distribution of GFAP+ astrocytes in the penumbra of young and old mice at 5 dpi. Note that the region covered by GFAP+ immunoreactivity in the
injured cerebral cortex of 18-month-old animals was larger compared with 2-month-old animals, but the tissue in the close vicinity to the lesion in old mice contain
a lower density of GFAP+ astrocytes than in young ones. (C) The ﬂuorescence micrograph panels reveal the morphological changes in astroglial cells at different dis-
tance to the injury site at 5 dpi, as indicated in B. Note that the morphological appearance of GFAP+ astrocytes located in the close proximity to the lesion (within
300 μm) in old animals was reduced. With increasing distance from the lesion core, some bushy astrocytes exhibited ﬁne GFAP+ cell processes (white arrowheads)
within the individual domains (as indicated by the dashed line), even at a long distance to the lesion (~800 μm). (D) At 5 dpi, absolute numbers of GFAP+S100β+ and
GFAP+S100β+BrdU+ cells within the parenchyma adjacent to injury site (within 300 μm) decreased signiﬁcantly with aging. (E) Immunostaining reveals an age-related
expansion of the BrdU+ cell pool and depletion of reactive astrocytes entering the cell-cycle (BrdU+GFAP+) in the injured GM parenchyma throughout 5 days after
injury. (F) A progressive depletion of the proliferating astrocyte pool over the course of aging occurs concomitantly with an increase in absolute numbers of BrdU+
cells in the post-traumatic GM. (G) Pie charts show the signiﬁcantly reduced proportion of GFAP+BrdU+ cells almost all cycling (BrdU+) cells in the injured GM of 18-
month-old mice compared with 2-month-old animals at 5 dpi. (H) Statistical analysis of Ki67+ and Ki67+GFAP+ cell numbers in the penumbra of aged mice at 5 dpi.
(I) The majority of Ki67+GFAP+ cells within 500μm of the injured GM in 2-, 9-, and 18-month-old mice were located at the surface of vessels (CD31+) (white arrow-
heads). Note that the bias of reactive astrocytes to proliferate at the interface of blood vessels remained unaffected by aging, as in all groups of animals the majority
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when proliferation of microglia and NG2+ glia has already
decreased (Simon et al. 2011), the age-dependent effect on the
entire cycling pool of reactive astrocytes was examined by
continuous administration of BrdU for 5 days, starting at 2 h
after injury. At this time point after injury, the number of pro-
liferating astrocytes in the penumbra of old compared with
young mice was reduced by ~40% (Fig. 2D–E). This decreased
proliferative activity was rather speciﬁc for astrocytes, as the
total pool of BrdU+ cells strikingly increased with aging
(Fig. 2E), and was nearly doubled in the penumbra of 18-
month-old mice compared with young mice (Fig. 2F). Notably,
the majority of BrdU+ cells in the injured GM of old animals
were microglia, whose proliferation increased signiﬁcantly
(60.0 ± 1.9% vs. 77.5 ± 2.1% of BrdU+Iba1+ among all BrdU+
cells within the injured GM of 2-month-old vs. 18-month-old
animals, respectively; P = 0.0003) (see Supplementary Fig. 2A,B),
while the proliferation of astrocytes and NG2+ glia decreased
with aging (20.1 ± 1.9% vs. 8.8 ± 1.4% of BrdU+NG2+ among all
BrdU cells within the injured GM of 2-month-old vs. 18-month-
old animals, respectively; P = 0.0001). Indeed, the contribution
of proliferating astrocytes (BrdU+GFAP+) was reduced to ~6% of
all cells that proliferate within the ﬁrst 5 days after injury in 18-
month-old mice, compared with ~22% in young animals
(Fig. 2G).
We proceeded to examine the cells dividing at 5 dpi by label-
ing for Ki67. Notably, opposed to cells labeled with BrdU for the
entire time after injury, the total number of Ki67+ cells was sig-
niﬁcantly decreased in an age-dependent fashion, starting
already at 9 months of age (Fig. 2H). Compared with young mice,
the total pool of Ki67+ cells at 5 dpi in 18-month-old mice shrank
by ~30%, and for GFAP+Ki67+ this effect was ~40% (Fig. 2H,I).
Interestingly, however, the bias of reactive astrocytes to prolifer-
ate at the interface of blood vessels remained unaffected by
aging, as in all groups of animals the majority of Ki67+GFAP+
cells within the injured GM was found at juxtavascular positions
(Fig. 2I). Thus, the glial population that had an increased prolifer-
ative response in the aged brain, namely microglia, did not show
prolonged proliferation (see Supplementary Fig. 2C). Rather, the
proliferative response in the old GM is decreased at 5 dpi, includ-
ing a signiﬁcant decrease in reactive astrocyte proliferation.
Modulation of Sonic Hedgehog Signaling can no Longer
Boost Proliferation of Reactive Astrocytes in the Injured
GM of Aged Mice
Given that the deﬁcits in proliferative behavior of cells in the
aging brain, e.g., neural stem cells (NSCs), have been shown to
be caused by reduced niche signals (e.g., growth factors and
cytokines) (Galvan and Jin 2007; Lee et al. 2012; Yun et al. 2015),
we aimed to determine to which extent providing such signals
could rescue the age-related decline in reactive astrocyte prolif-
eration. As Sonic hedgehog (Shh) signaling is a potent regulator
of astrocyte proliferation following injury (Bambakidis et al.
2012; Sirko et al. 2013), acting directly on reactive astrocytes in
young adult mice (Sirko et al. 2013), we investigated whether
the Smoothened (Smo) agonist SAG was sufﬁcient to boost pro-
liferation of reactive astrocytes in the penumbra of older mice.
Similar to observations in young adults, a daily systemic appli-
cation of SAG signiﬁcantly increased the number of Ki67+ cells
also in the injured GM of middle-aged and old animals (Fig. 3A,
B and D). Surprisingly, however, this effect was not exerted on
astrocytes in old animals, as the number of Ki67+GFAP+ cells
in the penumbra of these animals was not signiﬁcantly
increased upon treatment with SAG (28.9 ± 1.7 vs. 35.3 ± 2.2
Ki67+GFAP+ cells/mm2 injured GM of 18-month-old untreated
vs. SAG-treated animals, respectively; P = 0.19) (Fig. 3C,D).
Furthermore, reactive astrocytes contributed only to 20.1 ±
1.5% of the total Ki67+ cell pool labeled in the GM of old SAG-
treated mice at 5 dpi, in contrast to young SAG-treated mice
with 39.2 ± 1.7% GFAP+ of all Ki67+ cells. Thus, reactive astro-
cyte proliferation is not only higher in the injured GM of young
and middle-aged mice, but also particularly boosted by SAG,
while after 9 months of age proliferation of reactive astrocytes
is much lower and no longer susceptible to the boosting effect
of SAG (Fig. 3D).
Given the accelerated astrocyte reaction in aged poststroke
rodents (Badan et al. 2003) and the fact that astrocytes at 5 dpi
could not be stimulated to increase proliferation in the old
brains, we wondered if SAG would increase their proliferation
at earlier stages after injury. Therefore, we used again the con-
tinuous BrdU labeling for the entire 5 days after injury to detect
any cell proliferation changes in response to an enhanced Shh
signaling (Fig. 3A,B). Application of SAG caused a signiﬁcant
increase in BrdU+GFAP+ cells within the penumbra of young
and middle-aged animals, but the number of BrdU+ astrocytes
in old SAG-treated mice was not signiﬁcantly higher than in
the age-matched vehicle-treated controls (Fig. 3E). Indeed, only
10.5 ± 0.9% of all GFAP-labeled astrocytes proliferated within
the entire 5 days after injury, while this fraction was 20.6 ±
1.9% in young SAG-treated animals. In total, the number of
BrdU+GFAP+ cells was reduced by nearly 30% in the penumbra
of SAG-treated animals between 2 and 18 months (217.9 ± 15.9
vs. 156.1 ± 12.9 BrdU+GFAP+ cells/mm2 injured GM of 2- and
18-month-old mice, respectively).
Thus, the proliferation of reactive astrocytes in older ani-
mals could not be boosted at any time point after injury by
SAG-mediated stimulation of the Shh pathway, suggesting that
either other factors are missing in the injury environment or
cell-intrinsic changes are responsible for the substantially
diminished proliferative subset of reactive astrocytes in aged
animals. In this context, we also noted a clear trend toward
age-related downregulation of the mRNA levels of Shh trans-
ducer Smothened (Smo), Shh receptor Patched (Ptch1) and their
effector cyclin D1 (Ccnd1) in GFP+ astrocytes puriﬁed from
young and old Aldh1l1-eGFP mice at 5 dpi (Fig. 2K–M). These
data imply an interference with Shh pathway in aged reactive
astrocytes.
Age-Dependent Reduction of Proliferating Reactive
Astrocytes in Vitro
To minimize the effect of the environment, we decided to ana-
lyze cell divisions of reactive astrocytes by single-cell imaging
in vitro. Because the extent of astrocyte proliferation in vivo
does not signiﬁcantly change between 12 and 18 months of
of Ki67+GFAP+ cells within the injured GM was found at juxtavascular positions. (J–M) Bar graphs depicting levels of the mRNAs determined by qRT-PCR in GFP+ cells
puriﬁed by FACS from young and old Aldh1l1-GFP mice at 5 dpi (data are plotted as mean ± SEM of technical triplicates per separate age-groups of animals, as
described in Material and Methods section). All data in D, F, G, H, and I are plotted as mean ± SEM from n ≥ 3 experiments. Signiﬁcance between means was analyzed
using 2-tailed unpaired Student’s t-test or between multiple groups by 1-way ANOVA test and indicated as *P-value < 0.05, **P-value < 0.01, and ***P-value < 0.001. Cell
nuclei were counterstained with DAPI. Scale bars: 100 μm in (A, B, and E), 75 μm in (I) and 15 μm in (C).
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age, cell cultures of reactive glia were prepared from the injured
somatosensory GM of 2-, 6-, and 12-month-old animals at 5
dpi. These cultures contained several cell types, but were
highly enriched for astrocytes and microglia, while only few oli-
gogendroglial cells (~5%) and no neurons were found. Indeed,
at the starting point of live imaging, GFAP+ astrocytes together
with Iba1+ microglia comprised two-thirds of all adherent cells,
with no signiﬁcant differences between cultures prepared from
young and old brains (35.3 ± 1.9% and 30.9 ± 2.5% of GFAP+
cells and 40.2 ± 2.2% and 43.8 ± 2.0% of Iba1+ cells in the cell
cultures from 2- and 12-month-old mice, respectively; n = 3, P =
0.177, and P = 0.221). As neither the growth proﬁle of cell
Figure 3. Modulation of Shh signaling can no longer boost proliferation of reactive astrocytes in the injured GM of aged mice. (A, B) Immunostaining with BrdU and
Ki67 revealed that in vivo application of SAG modulated proliferative response of cells within the injured GM of young and old animals. (C) SAG-treatment in vivo
modulated the injury-induced astrocyte proliferation in young animals, but was not sufﬁcient to boost the proliferative activity in reactive astrocytes in old mice. (D)
Age-related changes in the numbers of Ki67+ cells and the reciprocal relationship between the numbers of Ki67+GFAP+ cells and the age of animals. (E) The incidence
of BrdU+ cells after application of SAG was signiﬁcantly elevated in young and middle-aged, but not in old animals, where the majority of BrdU+ cells was GFAP nega-
tive. All data are plotted as mean ± SEM from n ≥ 3 experiments. Signiﬁcance between means was analyzed using 2-tailed unpaired Student’s t-test or between multi-
ple groups by one-way ANOVA test and indicated as *P-value < 0.05, **P-value < 0.01, and ***P-value < 0.001. Cell nuclei were counterstained with DAPI. Scale bars: 75
μm in (A, B), 100 μm in (C).
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populations (see in Materials and Methods section) nor their
composition signiﬁcantly varied among reactive glia cultures,
these culture conditions are largely comparable.
To directly visualize dividing reactive astrocytes, we took
advantage of ﬂuorescent ubiquitylation-based cell-cycle indica-
tor (FUCCI)-S/G2/M-mAG-hGeminin mice (Sakaue-Sawano et al.
2008), which we bred with transgenic GFAP-mRFP1 mice
(Hirrlinger et al. 2005). The dual-color ﬂuorescence enabled us
to detect reactive astrocytes (GFAP-RFP+) in S/G2/M phases of
cell cycle by expression of FUCCI (mAG-hGeminin+) (Fig. 4A).
Continuous single-cell live imaging (Costa et al. 2011; Ortega
et al. 2013) further allowed us to follow the progeny of reactive
astrocytes for 7 days in vitro (div) (Fig. 4B,C).
Single-cell tracking analysis revealed that regardless of age,
the majority of GFAP-RFP+/mAG-hGeminin+ cells (95%) divided
within 36 h (Fig. 4D,E) and they remained in the astrocyte line-
age, as their progeny were all GFAP+ but not βIII-tubulin+ neu-
rons or O4+ oligodendrocytes (Fig. 4C). However, single
Figure 4. Age-related bias in the mode of cell divisions in aged reactive astrocytes and their progeny. (A) Scheme depicting the relationship between the cell-cycle
phases and expression of ﬂuorescent protein Azami-Green (mAG)-tagged Geminin (green) in RFP-GFAP+ (red) reactive astrocytes during S/G2/M phases of the cell
cycle. A representative example shows GFAP+/Geminin+ astrocyte in cell culture prepared from the injured GM of 2-month-old mice at 5 dpi. (B) After plating in the
adherent culture condition, proliferating GFAP-RFP+ cells (arrowheads) were distinguishable by expression of mAG-tagged Geminin (arrows). (C) Sequences of time-
lapse images revealed generation of cell colony from a single GFAP-RFP+/mAG-hGeminin+ cell at different time points in vitro. Post-imaging of immunolabeled cells
demonstrate that almost all generated daughter cells were GFAP+ (arrowheads). (D) Quantiﬁcation of the average length of division cycle revealed no signiﬁcant dif-
ferences in cell-cycle length of proliferative astrocytes isolated from different age-groups of the injured animals. (E) Examples of lineage trees obtained from single
dividing GFAP-RFP+/mAG-hGeminin+ cells show that proliferating astrocytes from each age-group of animals were capable to divide asymmetrically (light gray box),
symmetrically terminal (darker gray box), or proliferative (dark gray box) in vitro. (F) The number of cells per colony generated from single GFAP-RFP+/mAG-
hGeminin+ cell revealed substantial age-related differences, as shown by the frequency of clones at a given size among all clones generated. (G) Pie charts showing
the percent of asymmetrically, symmetrically terminal or proliferative dividing GFAP-RFP+ astrocytes obtained from 2-, 6-, and 12-month-old animals at 5 dpi. (H)
The proportion of proliferating progeny generated from GFAP-RFP+/mAG-hGeminin+ cell per cell clone decreased with aging. (I) The frequency of asymmetrically,
symmetrically terminal or proliferative dividing progeny of GFAP-RFP+/mAG-hGeminin+ cells revealed that reactive astrocytes lost their self-renewal capacity in an
age-dependent manner and divided predominantly symmetrically terminal with increasing age of animals. All data are plotted as mean ± SEM from n ≥ 3 indepen-
dent experiments. Signiﬁcance between means was analyzed using 2-tailed unpaired Student’s t-test or between multiple groups by one-way ANOVA test and indi-
cated as *P-value < 0.05, **P-value < 0.01, and ***P-value < 0.001. Scale bars: 20 μm in (A–C).
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proliferating astrocytes from the injured GM of young mice
generated a higher number of larger clones (>10 cells/clone)
than those from old animals (Fig. 4E,F).
Lineage tree analysis of individual GFAP-RFP+/mAG-
hGeminin+ cells showed that this was due to changes in their
cell division patterns, which we deﬁned based on the prolifera-
tion of the daughter cells. Although reactive astrocytes from
each age group were capable of dividing symmetrically and asym-
metrically (see Supplementary Movie 1–3), there were notable age-
related changes in the frequency of certain cell division modes
(Fig. 4G). For instance, the primary mode of the initial division of
young reactive astrocytes was symmetric proliferative (81%, 38/47),
resulting in the generation of 2 proliferating daughter cells (Fig. 4E,
G). Only 17% (8/47) of the initial divisions were terminal divisions
with the daughter cells no longer dividing during the observation
time and only 2% (1/47) dividing asymmetrically, generating one
proliferating and 1 non-proliferating daughter cell (Fig. 4E,G).
Under the same culture conditions, the proportion of symmetric
proliferative GFAP/RFP+ cells was, however, much reduced for cells
from older animals and comprised 66 or 46% of all reactive astro-
cytes isolated from middle-aged or old animals, respectively
(Fig. 4E,G). Conversely, symmetric terminal divisions were
increased to 22% (13/58) or even 34% (19/41) of all initial reactive
astrocyte divisions in reactive astrocyte cultures from the
injured middle-aged or old cerebral cortex GM, respectively
(Fig. 4E,G). Given that terminal cell division produces 2 nonpro-
liferative daughter cells, a 2-fold increase in terminally dividing
GFAP/RFP+/mAG-hGeminin+ cells isolated from 2 or 12-
month-old animals indicated a prominent age-related shift
toward cell-cycle exit, and hence, age-induced reduction in the
number of cells generated from a single reactive astrocyte
(Fig. 4H). This was also reﬂected in a progressive age-related
reduction in repetitive divisions of reactive astrocytes, as many
of them divided in symmetric terminal mode already at the
ﬁrst division (Fig. 4G). Conversely, the progeny of young mAG-
hGeminin+ reactive astrocytes underwent up to 4 rounds of
divisions and produced a relatively large number of proliferat-
ing cells before exiting the cell cycle (Fig. 4E,H,I).
During analyses of time-lapse data, we also noted that prog-
eny cells produced through 66% of all recorded divisions of aged
GFAP/RFP+/mAG-hGeminin+ astrocytes underwent cell death,
while in young or middle-aged cultures it was the case in 54% or
51% of reactive astrocyte divisions, respectively. Moreover, also
the average ratio of dying-to-surviving progeny cells increased
with age of dividing astrocytes (9% : 91% vs. 14% : 86% vs. 16% :
84% in the cell cultures from 2-, 6-, and 12-month-old mice,
respectively). It is important to note, that irrespectively of age,
cell death occurred more frequently through progeny produced
by non-terminal divisions of GFAP/RFP+/mAG-hGeminin+ cells,
and there was a positive correlation between the number of cell
divisions elapsed and the rate of cell death. On average 10.8 ±
2.1% of non-surviving progeny tend to undergo cell death after
their ﬁrst divisions, while 26.2 ± 5.9%, 29.1 ± 6.0%, and 33.9 ±
5.1% of them die after second, third, and fourth cell division
rounds, respectively. Together, these ﬁndings provide strong evi-
dence in support of the notion that age-related changes to the
proliferative program signiﬁcantly diminish the reproductive
ability of reactive astrocytes and together with reduced viability
in their progeny lead to the depletion of the subset of proliferat-
ing reactive astrocytes with age. Given these signiﬁcant differ-
ences in the behavior of young and aged proliferating reactive
astrocytes in an identical environment in vitro, it is likely that
age-related changes to the proliferative astrocyte response
reﬂect the changes at the cell-intrinsic level.
Reactive Astrocytes from the Aged GM Fail to Resume
the Symmetric Proliferative Mode of Division in
Response to Modulation of the Shh Signaling
Next, we aimed to examine how Shh signaling may inﬂuence
the mode of division of reactive astrocytes isolated from youn-
ger animals, and whether reactive astrocytes from older ani-
mals may at all react to Shh signaling, e.g., by changing the
mode of their division. Interestingly, addition of SAG to the cul-
ture medium led to a huge expansion of clones derived from
single astrocytes isolated from young mice (Fig. 5A and see
Supplementary Movie 4). This reaction was already much
attenuated for cells from 6-month-old mice and entirely absent
for reactive astrocytes from 12-month-old mice (10.3 vs. 2.1% of
clones containing >20 cells in SAG-treated cultures from young
vs. old injured mice, respectively; Fig. 5B,D).
Since the ability to form larger colonies could be due to the
shortening of cell-cycle length, we measured the time between
cell divisions. Indeed, when compared with control cultures of
the same age, SAG-treatment signiﬁcantly accelerated the cell-
cycle time of young reactive astrocytes and their progeny (29.7 ±
2.8 h vs. 21.8 ± 1.3 h in control vs. SAG-treated cultures, respec-
tively, P = 0.017). Conversely, the cell-cycle length of reactive
astrocytes derived from old animals remained unchanged (24.5
± 2.9 h vs. 23.3 ± 1.8 h in control vs. SAG-treated cultures,
respectively). It is, however, noteworthy, that the cycle length
without SAG addition is not slower for reactive astrocytes
derived from old animals indicating that the failure to produce
more progeny is not due to age-related differences in cell-cycle
length, but rather the mode of division and the ability of their
progeny to re-enter the cell-cycle (Fig. 5C,D). Therefore, we next
analyzed to what extent re-entry into cell cycle was affected by
SAG addition to the cultures of reactive astrocytes isolated
from young and old mice. Indeed, the direct progeny of young
GFAP-RFP+ cells underwent up to 6 rounds of cell division in
the SAG-containing culture, thereby massively amplifying the
pool of dividing progeny derived from a single proliferative
astrocyte (Fig. 5B,D). Although enhanced Shh signaling was suf-
ﬁcient to mediate proliferative divisions in young reactive
astrocytes, it was not sufﬁcient to do so in aged reactive astro-
cytes (Fig. 5B,C). Indeed, in presence of SAG ~90% of progeny
derived from the young GFAP-RFP+/mAG-hGeminin+ cells were
dividing in a symmetric or asymmetric proliferative mode,
while this proportion was already diminished to 60% for astro-
cytes derived from 6-month-old animals. At 12 months of age,
only one-third of the astrocyte progeny underwent proliferative
division, and modulation of the Shh pathway did not increase
this proportion (Fig. 5E). Likewise, SAG could not elicit repetitive
divisions of astrocytes from 12-month-old mice, as only 2%
were able to undergo more than 3 rounds of divisions. Thus,
the effects of SAG-treatment are due to the shortening of cell-
cycle length and a strongly increased re-entry into cell cycle of
astrocytes from young adult mice, but remain without effects
even in vitro for proliferating astrocytes from older mice.
Alteration of Injury-Induced Stem Cell Response
in Aging
As proliferation of reactive astrocytes goes hand in hand with
the acquisition of stem cell potential determined by generation
of self-renewing neurospheres (Buffo et al. 2008; Sirko et al.
2009, 2013), we investigated the consequences of the above
described age-related decrease in astrocyte proliferation on
their injury-induced stem cell capacity that was assayed by
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neurosphere formation. Of note, our stab wound injury para-
digm is restricted to the GM and placed in the somatosensory
cerebral cortex at a distance sufﬁcient to avoid migration from
the stem cell niche, the subependymal zone (SEZ) (Buffo et al.
2008; Sirko et al. 2013, 2015). At 5 dpi, cells from the GM
surrounding the injury site in animals of all age groups were
dissociated and plated in neurosphere medium for 14 days.
Notably, we observed that the number of neurosphere-forming
cells decreased in an age-dependent manner, with less than
half the number of neurospheres obtained from reactive glia
Figure 5. Modulation of Shh signaling induces re-entering in the cell cycle of young but not aged reactive astrocytes. (A) Time-lapse sequences obtained by video micros-
copy (RFP in upper panel, phase-contrast in lower panel) at different time points (hour:minute) show examples of cell colonies generated from single GFAP+/hGeminin+
cells under control condition (w/o, a1) or in SAG-containing culture medium (a2). Lineage trees show the effect of SAG addition, which in contrast to the control situa-
tion (a1), largely mediated generation of proliferating progeny from single GFAP-RFP+/mAG-hGeminin+ cell (a2) (“x” indicates cell death and cells that moved out the
visual ﬁeld are marked with “?”). (B) Overview of distinct lineage trees obtained from dividing GFAP+/hGeminin+ cells in the SAG-containing cultures isolated from 2-
and 12-month-old animals at 5 dpi. (C) Pie charts showing the percentage of asymmetrically, symmetrically terminal, or proliferative dividing astrocytes obtained
from 2-, 6-, and 12-month-old animals at 5 dpi and cultured in the presence of SAG for 7 day. (D) Bar charts depict the age-associated decrease in the number of divid-
ing progeny among all daughter cells generated from single GFAP+/hGeminin+ cells in SAG-containing culture medium. (E) A progressive age-related exhaustion of
symmetrically proliferative dividing progeny mirrors the loss of self-renewal in reactive astrocytes, even after exposure to SAG. (F) Statistical analysis uncovered the
signiﬁcant age-dependent reduction of neurosphere-forming cells in the penumbra, with no signiﬁcant changes by exposure to SAG in vitro. (G) Analyses of individ-
ual neurospheres at 14div revealed that the aged reactive astrocytes give rise to smaller neurospheres, even in the presence of SAG in the culture medium. (H)
Quantiﬁcation of neurosphere numbers per 10.000 plated cells indicated the reduced long-term capacity to self-renew of neurospheres derived from aged (red line)
compared to young (blue line) reactive astrocytes. All data are plotted as mean ± SEM from n ≥ 3 experiments. Signiﬁcance between means was analyzed using 2-
tailed unpaired Student’s t-test or between multiple groups by 1-way ANOVA test and indicated as *P-value < 0.05, **P-value < 0.01, and ***P-value < 0.001. Scale bars:
40 μm in (A) and 50 μm in (G).
Age-Related Changes in Reactive Astrocyte Plasticity Heimann et al. | 4223
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/8/4213/3798185 by guest on 11 N
ovem
ber 2019
isolated from 18-month-old animals (Fig. 5F). While the number
of neurospheres is an indicator for the number of cells with
stem cell properties, the diameter of neurospheres reﬂects the
proliferative activity of these cells and their progeny. As
expected from the above analysis, young reactive astrocytes, in
contrast to the old ones, generated a signiﬁcantly higher num-
ber of large neurospheres (≥150 μm) (Fig. 5G), indicating that the
age-related decline in NSC numbers is also paralleled with an
age-related decline in proliferation kinetics within individual
neurospheres. This reduced expansion of neurosphere cells is
well consistent with a progressive failure of aging reactive
astrocytes to divide repeatedly, as previously observed under
adherent culture conditions. Moreover, passaging of primary
neurospheres of equivalent size (100–150 μm in diameter) and,
hence, approximately equivalent cell numbers, resulted in a
signiﬁcantly lower number of secondary neurospheres in cul-
tures derived from old compared to young mice. This ﬁnding
indicated an age-related decrease in the proportion of self-
renewing NSCs within the neurospheres, consistent with
increased symmetric terminal divisions of reactive astrocytes
observed above by time-lapse imaging. Notably, the serial pas-
saging of neurospheres at a constant cell density showed that
neurospheres formed in cultures of cells from old mice dis-
played signiﬁcantly reduced self-renewal capacity compared to
cultures from young mice, with a complete exhaustion of neu-
rosphere cultures derived from 18-month-old mice already
after the passage 5. This reduced self-renewal of neurospheres
thus demonstrates a severe restriction in the self-renewal
capacity of the few cells with the NSC capacity observed after
stab wound injury in 18-month-old mice (Fig. 5H).
As expected from the above experiments, SAG addition to
the culture medium could no longer increase the number of
primary neurospheres formed from reactive glia derived from
12- or 18-month-old mice, while a signiﬁcant increase was
detected for cells derived from younger animals (Fig. 5F).
Besides the modulation of neurosphere-forming capacity, the
presence of SAG also stimulated the proliferation of cells within
neurospheres, as evident by the signiﬁcantly higher number of
larger primary neurospheres, especially in SAG-treated cultures
from young animals (Fig. 5G). A tendency to form larger neuro-
spheres was observed in cultures derived from the GM injury
site of 18-month-old mice, nevertheless they were quite rare,
generally less than 20% of all neurospheres (vs. ~40% in cul-
tures of young GM cells) (Fig. 5G). Accordingly, addition of SAG
could not signiﬁcantly boost the neurosphere-forming capacity
in aged reactive astrocytes, thus resulting in the appearance of
fewer and smaller primary neurospheres.
Discussion
In this study, we investigated the impact of aging on the injury-
induced plasticity in cerebrocortical astrocytes, and are now
demonstrating that aged reactive astrocytes in the post-
traumatic somatosensory GM display an altered proliferative
phenotype that subsequently leads to reduction of astrocyte
numbers in the injured GM parenchyma.
In light of the highly heterogeneous and region-speciﬁc
effects of aging on astrocytes (Shapira et al. 2002; Toescu 2005;
Lewis et al. 2012; Rodriguez-Arellano et al. 2016), we ﬁrst dem-
onstrated the changes in the somatosensory GM astrocytes in
relation to physiological aging in mice. Our observations show
that astrocytes in this area of the cerebral cortex acquire an
activated state in the upper layers with aging, and similarly to
astrocytes in other regions of brain (Rodriguez et al. 2014),
display upregulation of GFAP starting already in middle-aged
animals. However, in contrast to astrocytes within, for exam-
ple, the entorhinal cortex (Rodriguez et al. 2014), GFAP+ astro-
cytes in the somatosensory GM also develop a hypertrophic
morphology. This switch of state in aging cortical astrocytes is
paralleled with changes at the transcriptional level indicating
“certain” alterations in astrocyte physiology with age. We
found, for instance, that the GFAP+ astrocytes from the old
somatosensory GM exhibit in average about ∼30% higher levels
of Glul mRNA (glutamine synthetase, GS) than GFAP+ astro-
cytes in this GM region of young brains (see Supplementary
Fig. 1C). As a central enzyme for glutamine–glutamate/GABA
shuttle and for ammonium detoxiﬁcation, GS is an essential
part of the astrocyte-neuron signaling process (Rose et al. 2013)
and changes in GS expression and/or activity may lead to dif-
ferent brain pathologies, including neurodegenerative diseases
and mental disorders (Steffens et al. 2005; Steffek et al. 2008;
Sun et al. 2013). Interestingly, while an increased expression of
GS through ischemic postconditioning has been shown to be
neuroprotective in ischemic rats (Zhang et al. 2011), it appears
that the region-selective alterations in GS expression during
physiological aging (Rodriguez et al. 2014) are related to the
changes along a metabolic-inﬂammatory axis that support the
functionality switch of astrocytes from neurotrophic to neuro-
toxic with age (Rose and Felipo 2005; Jiang and Cadenas 2014).
Indeed, there is a tight association between alterations in meta-
bolic functions and an increased expression of genes character-
istic for an inﬂammatory state because of astrocyte aging (Orre
et al. 2014). Thus, acquisition of an inﬂammatory phenotype in
astrocytes during physiological aging may be the cause/conse-
quence of either local or systemic imbalance between pro- and
anti-inﬂammatory cytokine levels occurring with age (von
Bernhardi et al. 2015), thus favoring the so-called “inﬂamma-
ging” theory, which regard brain aging as a chronic neuroin-
ﬂammation (Franceschi 2007). However, our observations
suggest considerable regional speciﬁcity in both the degree and
cellular basis of the “inﬂammaging”. First, in contrast to other
brain regions where microglia adopt an activated state during
aging (von Bernhardi et al. 2010), we found no signiﬁcant differ-
ences either in the number or morphology of microglia
between the somatosensory GM of young and old mice.
Second, although glia in several brain regions respond to aging
with an increased proliferation (Buga et al. 2008; Acaz-Fonseca
et al. 2015), we did not ﬁnd any signs of induced proliferative
activity either in astrocytes or in other types of glia in the
somatosensory GM of middle-aged or even aged mice. These
observations are also corroborated by genome-wide expression
analysis showing a markedly upregulated expression of anti-
proliferation genes (including cyclin-dependent kinase inhibi-
tor 1B, also known as p27) in the healthy cerebral cortex of
aged rats (Buga et al. 2008). In this context, our data also show
that the total number of astrocytes in this cerebral region does
not change, indicating maintenance of the astroglial population
within their physiological range during aging.
Our observations in the intact GM thus provide support for
the concept of regional speciﬁcity of age-related dysregulations
in the signaling events (Raz et al. 2005; Rodriguez et al. 2014;
von Bernhardi et al. 2015; Verkhratsky et al. 2016), which can
also be translated into the region-speciﬁc response of aging
glia, including the reaction of aged astrocytes to injury. As with
prior studies of post-injured aged animals (Badan et al. 2003;
Acaz-Fonseca et al. 2015; Chisholm et al. 2015; Moraga et al. 2015),
the stab wounding to the somatosensory GM induces severe reac-
tive gliosis in aged mice. Also in agreement with previous studies,
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we found that the process of aging progressively increases the
proliferative response in the post-traumatic GM (as shown by the
numbers of BrdU+ cells), especially of microglia, since ~70% of
BrdU+ cells in the aged group of animals corresponded to reactive
Iba1+ microglia (see Supplementary Fig. 2A,B). Of particular
importance, however, is the distinct response of other glial cells,
the astrocytes, which show a continuous age-related decrease in
proliferation in the post-traumatic GM. In fact, the frequency of
proliferating astrocytes in aged mice was signiﬁcantly reduced,
compared with young mice. This observation is in agreement
with previous reports demonstrating that astrocytes in aged post-
stroke rats develop reduced proliferative response compared with
young rats (Buga et al. 2008; Acaz-Fonseca et al. 2015). However,
in other areas of the brain, for example, the hippocampus, an
age-related increase in astrocyte proliferation has been reported
(Buga et al. 2008; Acaz-Fonseca et al. 2015). The differences in the
proliferative response of astrocytes suggest distinctive region-
speciﬁc differences in astrocytes (Lundgaard et al. 2014), which
might have a region-speciﬁc susceptibility to aging, reﬂecting dis-
tinct requirements for maintenance of their plasticity after injury.
In light of our ﬁnding that the injury-induced proliferative
program fails to work in aging GM astrocytes, one of the main
ﬁndings of our study is that this phenomenon is the conse-
quence of changes in the multitude of their cell divisions. By
our experimental approach in vitro, we provided the ﬁrst dem-
onstration that the proliferating reactive astrocytes progres-
sively fail to re-enter the cell cycle with increasing age, while
their cell-cycle length remains unaffected. This switch in the
proliferative program adversely inﬂuences the outcome of
astrocyte divisions, and sets the stage for a progressive deple-
tion of the proliferating astrocyte pool over the course of aging
along with a reduced stem cell potential. This raises the funda-
mental question of whether the loss of the potential to self-
renew and proliferate in aging reactive astrocytes is entirely
irreversible. Given that Shh not only controls the self-renewal
rate of the astrocyte-like NSCs by modulation of their prolifer-
ative divisions in the adult SEZ (Ferent et al. 2014), but is also
necessary and sufﬁcient to promote stem cell properties in
reactive astrocytes (Sirko et al. 2013), it was interesting to ﬁnd
that the treatment with SAG, which enhances the Shh path-
way, mediates and increases proliferative divisions of reactive
astrocytes from young but not aged animals. Consistent with
this, the pool of proliferating astrocytes within the penumbra
of aged GM still remains reduced following SAG-treatment
in vivo.
It is important to note that the SAG-mediated activation of
Smo induces the transcriptional activation of the Gli1 zinc ﬁn-
ger transcription factors in young reactive astrocytes during the
ﬁrst 24 h after systemic SAG application (see Supplementary
Fig. 3) indicating that SAG acts directly on the astrocytes. This
is also corroborated by data showing that selective deletion of
Smo in astrocytes using GLASTCreERT2-mediated recombination
or pharmacological inhibition of Smo signiﬁcantly decreased
transcriptional activation of the Shh/Gli signaling cascade and
their effector Ccnd1 in reactive astrocytes, leading to the reduc-
tion in astrocyte proliferation and their stem cell response to
the injury (Sirko et al. 2013). By these means, the age-related
downregulation of Smo expression in astrocytes shown here
may affect G1/S transition by the cell-cycle regulator Ccnd1,
preventing thereby transition of aged reactive astrocytes from
quiescent to cycling states, even after exposure to SAG.
Nevertheless, there may be many other age-related alterations
in other molecular pathways, such as Notch signaling. For
example, the interaction between Shh and Notch signaling
pathways is required for the regulation of cell divisions during
corticogenesis and in the adult SEZ (Ferent et al. 2014).
It was interesting to observe that the age-related reduction
in the rate of reactive astrocyte proliferation is perpetuated
also in vitro, where the complexity of the environment is
reduced and no access to the lesion-derived diffusible mor-
phogens from the liquor and serum at sites of disrupted
blood-brain barrier (BBB) or other mediators produced by
inﬂammatory cells at the injury site. Nonetheless, we cannot
exclude that there are some modiﬁcations in the microenvi-
ronment of cultured cells due to the various factors secreted
from microglia as they also exhibit phenotypic changes with
age (Orre et al. 2014).
It is thus tempting to speculate that defects in the injury-
induced plasticity of aged astrocytes is likely due to their intrin-
sic aging rather than due to reversible environmental changes,
such as age-associated reduction of the Shh levels in plasma,
niche, or systemically circulating factors (e.g., IGF-1, FGF-2, EGF,
and VEGF) (El-Zaatari et al. 2012). The changes shown here fur-
ther argue that the failure of astrocytes to elicit a proper prolif-
erative response in the penumbra of aged brains likely reﬂects
a manifestation of cell-intrinsic changes over the course of
aging. Further work will have to address to what extent the
age-dependent changes to the microenvironment may act
either synergistically with intrinsic modiﬁcations or in addition
to the decreased proliferation of reactive astrocytes. Our study
characterized the changes to the proliferative program as a
phenotypic characteristic of aged reactive astrocytes that pro-
voke a decrease in the number of proliferating astrocytes in the
aged post-traumatic GM. We further provided evidence sug-
gesting the interference with Shh signaling pathway as impli-
cated in the disability of aged astrocytes to renew themselves
by either symmetric or asymmetric division. The challenge,
therefore, will be to determine precisely these speciﬁc “off”
mechanisms, which trigger the quiescent state of aged astrocytes
throughout their response to injury of the cerebral cortex GM.
It should be noted that in analogy to reactive GM astrocytes,
impairment of proliferation is also apparent in NSCs in the
aged brain and linked to the depletion of their cell division,
resulting in generation of nondividing progeny (Encinas et al.
2011; Lee et al. 2012; Calzolari et al. 2015). Several factors that
underlie such an age-related limitation of NSC properties
include the progressive lack of telomerase activity (Wong et al.
2003; Ferron et al. 2009; Jaskelioff et al. 2011). Interestingly, at
this age the poststroke mice also show selectively affected pro-
liferation of NSCs (also called Type-B cells) and Type-C cells,
the proliferating progenitors that originate from the NSCs in
the SEZ (Moraga et al. 2015). Since the proliferating GM astro-
cytes represent a plastic population of astroglia outside the
neurogenic niches (Buffo et al. 2008; Sirko et al. 2009, 2013,
2015; Götz and Sirko 2013), the intrinsic changes to the prolifer-
ative/renewal program seem to be a common characteristic of
proliferation-competent astroglia in the aged brain. It is, there-
fore, conceivable that mechanisms proposed to explain the
intrinsic aging of NSCs, including telomere shortening, accu-
mulation of DNA damage, or epigenetic alterations (Rando
2006; Drummond-Barbosa 2008) can also contribute to age-
dependent exhaustion of proliferative activity in reactive GM
astrocytes.
Since astrocyte proliferation is the only way to increase their
numbers in the cortical GM (Bardehle et al. 2013), we have also
demonstrated that insufﬁciency in maintaining proliferative
astrocyte response in the aged post-injured GM ultimately
results in the failure of astrocyte homeostasis in the penumbra
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of aged mice. Given that restoration of the astroglial equilib-
rium represents an essential step to ensure certain repair
mechanisms following tissue damage, that is, neuroprotection,
proper reconstruction of the BBB, initiating and perpetuating
cerebral immune response, physical fencing of the damaged areas
or a removal of pathogens through phagocytosis (Cordiglieri and
Farina 2010; Götz and Sirko 2013; Sirko et al. 2015; Verkhratsky
et al. 2016), it is not surprising that an age-related deﬁcit in the
establishment of a particularly plastic and immature set of
astrocytes (Fitch and Silver 2008) may in some instances alter
the outcome after damage in the aged brain. Indeed, we have
found that aged mice show an exacerbated parenchymal dam-
age compared to younger animals at the same time point after
injury, including a larger reactive perimeter within the penum-
bra as well as a higher number of inﬁltrating CD45+ cells in the
injured GM parenchyma (data not shown). Moreover, it is also
conceivable that the signiﬁcantly prolonged BBB leakage in the
post-traumatic GM of old animals (Supplementary Fig. 4) can
inﬂuence survival rate of astrocytes at the injury site, and in
addition to the drop of proliferating astrocytes, can contribute
to a loss of astrocytes in the parenchyma surrounding the
lesion in the aged brain. In addition, premature formation of
scar-like tissue as well as diminished poststroke recovery of
aged animals have been previously correlated also with abnor-
mal reactivity of aging glial cells to damage in the brain (Acaz-
Fonseca et al. 2015; Moraga et al. 2015).
Thus, our present results not only extend previous ﬁndings
on age-related effects of the response of glial cells to an inva-
sive injury but also highlight that cell-intrinsic changes in reac-
tive astrocytes contribute to the adverse outcome of astrocyte
proliferation within the injured GM parenchyma, affecting
thereby astrocyte homeostasis in the damaged area. Future
studies should, therefore, focus on a region-speciﬁc analysis of
reactive astrocyte plasticity during aging, since our present
data support the hypothesis that the decline in regenerative
potential and impairment of post-traumatic recovery of brain
parenchyma during aging may result from speciﬁc age-related
changes in astrocyte proliferation.
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Supplementary material is available at Cerebral Cortex online.
Funding
This work was supported by the Friedrich Baur Foundation
(Grant nos. 822646 and 822395 to S.S.); the German Research
Foundation (SPP 1757 and SFB 870 to M.G.); the European
Research Council (Grant no. 340793 to M.G.); Excellence Cluster
of Systems Neurology Synergy (M.G.) and the Helmholtz
Alliance Icemed (M.G.).
Notes
We thank Tatiana Simon-Ebert and Detlef Franzen for great
technical assistance, and Dr. Stefan H. Stricker for excellent
comments on the manuscript. Conﬂict of Interest: None declared.
References
Acaz-Fonseca E, Duran JC, Carrero P, Garcia-Segura LM, Arevalo
MA. 2015. Sex differences in glia reactivity after cortical
brain injury. Glia. 63:1966–1981.
Alexander MP. 1994. Stroke rehabilitation outcome. A potential
use of predictive variables to establish levels of care. Stroke.
25:128–134.
Anderson MA, Burda JE, Ren Y, Ao Y, O’Shea TM, Kawaguchi R,
Coppola G, Khakh BS, Deming TJ, Sofroniew MV. 2016.
Astrocyte scar formation aids central nervous system axon
regeneration. Nature. 532:195–200.
Badan I, Buchhold B, Hamm A, Gratz M, Walker LC, Platt D,
Kessler C, Popa-Wagner A. 2003. Accelerated glial reactivity
to stroke in aged rats correlates with reduced functional
recovery. J Cereb Blood Flow Metab. 23:845–854.
Bambakidis NC, Petrullis M, Kui X, Rothstein B, Karampelas I,
Kuang Y, Selman WR, LaManna JC, Miller RH. 2012.
Improvement of neurological recovery and stimulation of
neural progenitor cell proliferation by intrathecal adminis-
tration of Sonic hedgehog. J Neurosurg. 116:1114–1120.
Bardehle S, Kruger M, Buggenthin F, Schwausch J, Ninkovic J,
Clevers H, Snippert HJ, Theis FJ, Meyer-Luehmann M,
Bechmann I, et al. 2013. Live imaging of astrocyte responses
to acute injury reveals selective juxtavascular proliferation.
Nat Neurosci. 16:580–586.
Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, Mori T,
Gotz M. 2008. Origin and progeny of reactive gliosis: a source
of multipotent cells in the injured brain. Proc Natl Acad Sci
USA. 105:3581–3586.
Buga AM, Sascau M, Pisoschi C, Herndon JG, Kessler C, Popa-
Wagner A. 2008. The genomic response of the ipsilateral
and contralateral cortex to stroke in aged rats. J Cell Mol
Med. 12:2731–2753.
Burda JE, Sofroniew MV. 2014. Reactive gliosis and the multicel-
lular response to CNS damage and disease. Neuron. 81:
229–248.
Calzolari F, Michel J, Baumgart EV, Theis F, Gotz M, Ninkovic J.
2015. Fast clonal expansion and limited neural stem cell
self-renewal in the adult subependymal zone. Nat Neurosci.
18:490–492.
Chisholm NC, Henderson ML, Selvamani A, Park MJ, Dindot S,
Miranda RC, Sohrabji F. 2015. Histone methylation patterns
in astrocytes are inﬂuenced by age following ischemia.
Epigenetics. 10:142–152.
Copen WA, Schwamm LH, Gonzalez RG, Wu O, Harmath CB,
Schaefer PW, Koroshetz WJ, Sorensen AG. 2001. Ischemic
stroke: effects of etiology and patient age on the time course
of the core apparent diffusion coefﬁcient. Radiology. 221:
27–34.
Cordiglieri C, Farina C. 2010. Astrocytes exert and control
immune responses in the brain. Curr Immunol Rev. 6:
150–159.
Costa MR, Ortega F, Brill MS, Beckervordersandforth R, Petrone C,
Schroeder T, Gotz M, Berninger B. 2011. Continuous live
imaging of adult neural stem cell division and lineage pro-
gression in vitro. Development. 138:1057–1068.
Dostovic Z, Smajlovic D, Sinanovic O, Vidovic M. 2009. Duration
of delirium in the acute stage of stroke. Acta Clin Croat. 48:
13–17.
Drummond-Barbosa D. 2008. Stem cells, their niches and the
systemic environment: an aging network. Genetics. 180:
1787–1797.
El-Zaatari M, Daignault S, Tessier A, Kelsey G, Travnikar LA,
Cantu EF, Lee J, Plonka CM, Simeone DM, Anderson MA,
et al. 2012. Plasma Shh levels reduced in pancreatic cancer
patients. Pancreas. 41:1019–1028.
Encinas JM, Michurina TV, Peunova N, Park JH, Tordo J,
Peterson DA, Fishell G, Koulakov A, Enikolopov G. 2011.
4226 | Cerebral Cortex, 2017, Vol. 27, No. 8
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/8/4213/3798185 by guest on 11 N
ovem
ber 2019
Division-coupled astrocytic differentiation and age-related
depletion of neural stem cells in the adult hippocampus.
Cell Stem Cell. 8:566–579.
Ferent J, Cochard L, Faure H, Taddei M, Hahn H, Ruat M,
Traiffort E. 2014. Genetic activation of Hedgehog signaling
unbalances the rate of neural stem cell renewal by increas-
ing symmetric divisions. Stem Cell Rep. 3:312–323.
Ferron SR, Marques-Torrejon MA, Mira H, Flores I, Taylor K,
Blasco MA, Farinas I. 2009. Telomere shortening in neural
stem cells disrupts neuronal differentiation and neuritogen-
esis. J Neurosci. 29:14394–14407.
Fitch MT, Silver J. 2008. CNS injury, glial scars, and inﬂamma-
tion: Inhibitory extracellular matrices and regeneration fail-
ure. Exp Neurol. 209:294–301.
Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL,
Schwamm LH, Get With the Guidelines-Stroke Steering C,
Investigators. 2010. Age-related differences in characteris-
tics, performance measures, treatment trends, and out-
comes in patients with ischemic stroke. Circulation. 121:
879–891.
Franceschi C. 2007. Inﬂammaging as a major characteristic of
old people: can it be prevented or cured? Nutr Rev. 65:
S173–S176.
Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O,
Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J,
et al. 2002. Small-molecule modulators of Hedgehog signal-
ing: identiﬁcation and characterization of smoothened ago-
nists and antagonists. J Biol. 1:10.
Galvan V, Jin K. 2007. Neurogenesis in the aging brain. Clin
Interv Aging. 2:605–610.
Gargano JW, Wehner S, Reeves MJ. 2011. Presenting symptoms
and onset-to-arrival time in patients with acute stroke and
transient ischemic attack. J Stroke Cerebrovasc Dis. 20:
494–502.
Götz M, Sirko S. 2013. Potential of glial cells. In: Sell S, editor.
Stem cells handbook. 2nd ed. New York: Springer. p. 347–361.
Heinrich C, Bergami M, Gascon S, Lepier A, Vigano F, Dimou L,
Sutor B, Berninger B, Gotz M. 2014. Sox2-mediated conver-
sion of NG2 glia into induced neurons in the injured adult
cerebral cortex. Stem Cell Reports. 3:1000–1014.
Heintz N. 2004. Gene expression nervous system atlas
(GENSAT). Nat Neurosci. 7:483.
Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak
RA, Takeda K, Akira S, Sofroniew MV. 2008. STAT3 is a criti-
cal regulator of astrogliosis and scar formation after spinal
cord injury. J Neurosci. 28:7231–7243.
Hilsenbeck O, Schwarzﬁscher M, Skylaki S, Schauberger B,
Hoppe PS, Loefﬂer D, Kokkaliaris KD, Hastreiter S, Skylaki E,
Filipczyk A, et al. 2016. Software tools for single-cell tracking
and quantiﬁcation of cellular and molecular properties. Nat
Biotechnol. 34:703–706.
Hirrlinger PG, Scheller A, Braun C, Quintela-Schneider M, Fuss B,
Hirrlinger J, Kirchhoff F. 2005. Expression of reef coral ﬂuores-
cent proteins in the central nervous system of transgenic
mice. Mol Cell Neurosci. 30:291–303.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC,
Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J,
et al. 2011. Telomerase reactivation reverses tissue
degeneration in aged telomerase-deﬁcient mice. Nature.
469:102–106.
Jiang T, Cadenas E. 2014. Astrocytic metabolic and inﬂamma-
tory changes as a function of age. Aging Cell. 13:1059–1067.
Juraska JM, Lowry NC. 2012. Neuroanatomical changes associated
with cognitive aging. Curr Top Behav Neurosci. 10:137–162.
Lee SW, Clemenson GD, Gage FH. 2012. New neurons in an aged
brain. Behav Brain Res. 227:497–507.
Levine J, Kwon E, Paez P, Yan W, Czerwieniec G, Loo JA,
Sofroniew MV, Wanner IB. 2016. Traumatically injured
astrocytes release a proteomic signature modulated by
STAT3-dependent cell survival. Glia. 64:668–694.
Lewis DK, Thomas KT, Selvamani A, Sohrabji F. 2012. Age-
related severity of focal ischemia in female rats is associ-
ated with impaired astrocyte function. Neurobiol Aging. 33:
1123 e1121–1116.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expres-
sion data using real-time quantitative PCR and the 2(-Delta
Delta C(T)) Method. Methods. 25:402–408.
Lundgaard I, Osorio MJ, Kress BT, Sanggaard S, Nedergaard M.
2014. White matter astrocytes in health and disease.
Neuroscience. 276:161–173.
Lynch AM, Murphy KJ, Deighan BF, O’Reilly JA, Gun’ko YK,
Cowley TR, Gonzalez-Reyes RE, Lynch MA. 2010. The impact
of glial activation in the aging brain. Aging Dis. 1:262–278.
Middeldorp J, Hol EM. 2011. GFAP in health and disease. Prog
Neurobiol. 93:421–443.
Moppett IK. 2007. Traumatic brain injury: assessment, resusci-
tation and early management. Br J Anaesth. 99:18–31.
Moraga A, Pradillo JM, Garcia-Culebras A, Palma-Tortosa S,
Ballesteros I, Hernandez-Jimenez M, Moro MA, Lizasoain I.
2015. Aging increases microglial proliferation, delays cell
migration, and decreases cortical neurogenesis after focal
cerebral ischemia. J Neuroinﬂammation. 12:87.
Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C,
Hanisch UK, Kirchhoff F, Kettenmann H. 2001. GFAP
promoter-controlled EGFP-expressing transgenic mice: a
tool to visualize astrocytes and astrogliosis in living brain
tissue. Glia. 33:72–86.
O’Callaghan JP, Kelly KA, VanGilder RL, Sofroniew MV, Miller
DB. 2014. Early activation of STAT3 regulates reactive astro-
gliosis induced by diverse forms of neurotoxicity. PLoS ONE.
9:e102003.
Orre M, Kamphuis W, Osborn LM, Melief J, Kooijman L, Huitinga I,
Klooster J, Bossers K, Hol EM. 2014. Acute isolation and tran-
scriptome characterization of cortical astrocytes and microglia
from young and aged mice. Neurobiol Aging. 35:1–14.
Ortega F, Berninger B, Costa MR. 2013. Primary culture and live
imaging of adult neural stem cells and their progeny.
Methods Mol Biol. 1052:1–11.
Pekna M, Pekny M, Nilsson M. 2012. Modulation of neural plas-
ticity as a basis for stroke rehabilitation. Stroke. 43:
2819–2828.
Rando TA. 2006. Stem cells, ageing and the quest for immortal-
ity. Nature. 441:1080–1086.
Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D,
Williamson A, Dahle C, Gerstorf D, Acker JD. 2005. Regional
brain changes in aging healthy adults: general trends, indi-
vidual differences and modiﬁers. Cereb Cortex. 15:
1676–1689.
Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T.
2009. Hematopoietic cytokines can instruct lineage choice.
Science. 325:217–218.
Rodriguez JJ, Yeh CY, Terzieva S, Olabarria M, Kulijewicz-Nawrot
M, Verkhratsky A. 2014. Complex and region-speciﬁc changes
in astroglial markers in the aging brain. Neurobiol Aging.
35:15–23.
Rodriguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A. 2016.
Astrocytes in physiological aging and Alzheimer’s disease.
Neuroscience. 323:170–182.
Age-Related Changes in Reactive Astrocyte Plasticity Heimann et al. | 4227
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/8/4213/3798185 by guest on 11 N
ovem
ber 2019
Rose C, Felipo V. 2005. Limited capacity for ammonia removal
by brain in chronic liver failure: potential role of nitric oxide.
Metab Brain Dis. 20:275–283.
Rose CF, Verkhratsky A, Parpura V. 2013. Astrocyte glutamine
synthetase: pivotal in health and disease. Biochem Soc
Trans. 41:1518–1524.
Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H,
Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al.
2008. Visualizing spatiotemporal dynamics of multicellular
cell-cycle progression. Cell.. 132:487–498.
Shapira S, Sapir M, Wengier A, Grauer E, Kadar T. 2002. Aging
has a complex effect on a rat model of ischemic stroke.
Brain Res. 925:148–158.
Simon C, Gotz M, Dimou L. 2011. Progenitors in the adult cere-
bral cortex: cell cycle properties and regulation by physio-
logical stimuli and injury. Glia. 59:869–881.
Sirko S, Neitz A, Mittmann T, Horvat-Brocker A, von Holst A,
Eysel UT, Faissner A. 2009. Focal laser-lesions activate an
endogenous population of neural stem/progenitor cells in
the adult visual cortex. Brain. 132:2252–2264.
Sirko S, Behrendt G, Johansson PA, Tripathi P, Costa M, Bek S,
Heinrich C, Tiedt S, Colak D, Dichgans M, et al. 2013.
Reactive glia in the injured brain acquire stem cell proper-
ties in response to sonic hedgehog. [corrected]. Cell Stem
Cell. 12:426–439.
Sirko S, Irmler M, Gascon S, Bek S, Schneider S, Dimou L,
Obermann J, De Souza Paiva D, Poirier F, Beckers J, et al.
2015. Astrocyte reactivity after brain injury: The role of
galectins 1 and 3. Glia. 63:2340–2361.
Sofroniew MV. 2009. Molecular dissection of reactive astroglio-
sis and glial scar formation. Trends Neurosci. 32:638–647.
Sriram K, Benkovic SA, Hebert MA, Miller DB, O’Callaghan JP.
2004. Induction of gp130-related cytokines and activation of
JAK2/STAT3 pathway in astrocytes precedes up-regulation
of glial ﬁbrillary acidic protein in the 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine model of neurodegeneration: key
signaling pathway for astrogliosis in vivo? J Biol Chem. 279:
19936–19947.
Steffek AE, McCullumsmith RE, Haroutunian V, Meador-
Woodruff JH. 2008. Cortical expression of glial ﬁbrillary
acidic protein and glutamine synthetase is decreased in
schizophrenia. Schizophr Res. 103:71–82.
Steffens M, Huppertz HJ, Zentner J, Chauzit E, Feuerstein TJ. 2005.
Unchanged glutamine synthetase activity and increased NMDA
receptor density in epileptic human neocortex: implications for
the pathophysiology of epilepsy. Neurochem Int. 47:379–384.
Sun HL, Zhang SH, Zhong K, Xu ZH, Feng B, Yu J, Fang Q, Wang
S, Wu DC, Zhang JM, et al. 2013. A transient upregulation of
glutamine synthetase in the dentate gyrus is involved in
epileptogenesis induced by amygdala kindling in the Rat.
PLoS ONE. 8:e66885.
Toescu EC. 2005. Normal brain ageing: models and mecha-
nisms. Philos Trans R Soc Lond B Biol Sci. 360:2347–2354.
Unger JW. 1998. Glial reaction in aging and Alzheimer’s disease.
Microsc Res Tech. 43:24–28.
Verkhratsky A, Parpura V, Pekna M, Pekny M, Sofroniew M.
2014a. Glia in the pathogenesis of neurodegenerative dis-
eases. Biochem Soc Trans. 42:1291–1301.
Verkhratsky A, Rodriguez JJ, Parpura V. 2014b. Neuroglia in age-
ing and disease. Cell Tissue Res. 357:493–503.
Verkhratsky A, Zorec R, Rodriguez JJ, Parpura V. 2016. Astroglia
dynamics in ageing and Alzheimer’s disease. Curr Opin
Pharmacol. 26:74–79.
von Bernhardi R, Tichauer JE, Eugenin J. 2010. Aging-dependent
changes of microglial cells and their relevance for neurode-
generative disorders. J Neurochem. 112:1099–1114.
von Bernhardi R, Eugenin-von Bernhardi L, Eugenin J. 2015.
Microglial cell dysregulation in brain aging and neurodegen-
eration. Front Aging Neurosci. 7:124.
Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y,
Alt FW, DePinho RA. 2003. Telomere dysfunction and Atm
deﬁciency compromises organ homeostasis and accelerates
ageing. Nature. 421:643–648.
Yun HM, Kim JA, Hwang CJ, Jin P, Baek MK, Lee JM, Hong JE, Lee
SM, Han SB, Oh KW, et al. 2015. Neuroinﬂammatory and
amyloidogenic activities of IL-32beta in Alzheimer’s disease.
Mol Neurobiol. 52:341–352.
Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres
BA. 2012. Genomic analysis of reactive astrogliosis.
J Neurosci. 32:6391–6410.
Zhang L, Zhang RL, Wang Y, Zhang C, Zhang ZG, Meng H,
Chopp M. 2005. Functional recovery in aged and young rats
after embolic stroke: treatment with a phosphodiesterase
type 5 inhibitor. Stroke. 36:847–852.
Zhang W, Miao Y, Zhou S, Jiang J, Luo Q, Qiu Y. 2011.
Neuroprotective effects of ischemic postconditioning on
global brain ischemia in rats through upregulation of hippo-
campal glutamine synthetase. J Clin Neurosci. 18:685–689.
4228 | Cerebral Cortex, 2017, Vol. 27, No. 8
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/8/4213/3798185 by guest on 11 N
ovem
ber 2019
